Biblio
Journal Article
O'Hear C, Inaba H, Pounds S, Shi L, Dahl G, W Bowman P, Taub JW, Pui C-H, Ribeiro RC, Coustan-Smith E, et al. Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia. Cancer. 2013.